SHA:603858 Market Cap

SHA:603858 has a market cap or net worth of 17.61 billion as of April 8, 2026. Its market cap has increased by 10.32% in one year.

Market Cap

17.61B

Enterprise Value

19.38B

Revenue

10.96B

Ranking

n/a

PE Ratio

10,592.74

Stock Price

16.70

Market Cap Chart

Since November 18, 2016, SHA:603858's market cap has decreased from 54.86B to 17.61B, a decrease of -67.90%. That is a compound annual growth rate of -11.40%.

Market Cap History

Date	Market Cap	% Change
Apr 7, 2026	17.51B	6.14%
Dec 31, 2025	16.49B	-2.05%
Dec 31, 2024	16.84B	-10.50%
Dec 29, 2023	18.81B	-19.04%
Dec 30, 2022	23.24B	-0.38%
Dec 31, 2021	23.33B	-8.58%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Nov 18, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Tonghua Dongbao Pharmaceutical	19.24B
China Resources Double-Crane Pharmaceutical	19.18B
Betta Pharmaceuticals	18.59B
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	18.47B
Wedge Industrial	17.90B
Hybio Pharmaceutical	17.15B
China Resources Jiangzhong Pharmaceutical Co.,Ltd	16.88B
ApicHope Pharmaceutical Group	16.41B

Market Cap Rankings